Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Literature
1.
Palacios S, Espadaler J, Fernández-Moya JM, Prieto C, Salas N (2016) Is it possible to prevent recurrent vulvovaginitis? the role of Lactobacillus plantarum I1001 (CECT7504). Eur J Clin Microbiol Infect Dis 35:1701–1708CrossRefPubMedPubMedCentral
2.
3.
4.
Macklaim JM, Clemente JC, Knight R, Gloor GB, Reid G (2015) Changes in vaginal microbiota following antimicrobial and probiotic therapy. Microb Ecol Health Dis 26:27799PubMed
5.
6.
Hu Z, Zhou W, Mu L, Kuang L, Su M, Jiang Y (2015) Identification of cytolytic vaginosis versus vulvovaginal candidiasis. J Low Genit Tract Dis 19:152–155CrossRefPubMed
7.
Berg AO, Heidrich FE, Fihn SD, Bergman JJ, Wood RW, Stamm WE, Holmes KK (1984) Establishing the cause of genitourinary symptoms in women in a family practice. comparison of clinical examination and comprehensive microbiology. JAMA 251:620–625CrossRefPubMed
Metadata
Title
Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)
Authors
P. Vieira-Baptista
G. Donders
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2861-z

Other articles of this Issue 3/2017

European Journal of Clinical Microbiology & Infectious Diseases 3/2017 Go to the issue

Original Article

The association between illicit drug use and infectious complications among trauma patients

Original Article

Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial

Original Article

How obesity impacts outcomes of infectious diseases

Original Article

Paediatric antibiotic prescriptions in primary care in the Alpes-Maritimes area of southeastern France between 2008 and 2013

Review

MCR: modern colistin resistance

Original Article

High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits